Clinical development of levetiracetam for amyotrophic lateral sclerosis
- PMID: 17220961
Clinical development of levetiracetam for amyotrophic lateral sclerosis
Abstract
This month's Spotlight on... focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis. We highlight the experimental rationale behind its progress into patient cohorts with regards to targeting three currently untreatable aspects of human amyotrophic lateral sclerosis: cramps, spasticity and disease progression.
Copyright 2006 Prous Science. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Medical